Symphony Therapeutics, LLC was founded in 2022, as a spin-off of Bedford, MA-based Integral BioSystems, LLC. Symphony Therapeutics is developing products based on the patented OcuSurf LNP and NanoM delivery systems.
Symphony Therapeutics' products are focused on specific ophthalmic, otic and dermatologic indications using 505b2 regulatory approaches to rapidly gain approval and commercial access.
NanoM Wafer and OcuSurf technologies have been patented in global jurisdictions. Additionally, the technologies have been enabled in multiple indications in ophthalmology and dermatology.